TPGS-b-(PLA-ran-PGA) copolymer and preparation method and application thereof

A technology of pla-ran-pga and copolymer, which is applied in the fields of medical science, powder transportation, bulk transportation, etc., can solve the problem of lack of research, development and application of new pharmaceutical excipients, and achieve the effect of simple method and good biological phase

Inactive Publication Date: 2011-04-27
SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Without the research, development and application of new pharmaceutical excipien

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • TPGS-b-(PLA-ran-PGA) copolymer and preparation method and application thereof
  • TPGS-b-(PLA-ran-PGA) copolymer and preparation method and application thereof
  • TPGS-b-(PLA-ran-PGA) copolymer and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Embodiment 1, preparation TPGS-b-(PLA-ran-PGA) copolymer

[0038] Accurately weigh 7.5g (monomer total mass 75%) racemic lactide monomer (D, L-Lactide), 1.5g (monomer total mass 15%) glycolide monomer (Glycolide), 1g ( Monomer total mass 10%) Vitamin E TPGS (n=32, molecular weight 1513) is raw material, gets the catalyst stannous octoate of monomer gross mass 0.1% and adds in the polymer tube, carries out vacuum degassing and nitrogen replacement process, repeats Three times (to ensure the anaerobic condition of the equipment), the polymerization tube was sealed, and the ring-opening polymerization reaction was carried out under heating in an oil bath at 145°C. After 16 hours of polymerization, the product was cooled and dissolved in methylene chloride, and excess methanol was added to precipitate the copolymer. Methanol unreacted monomer and TPGS were removed by filtration. The resulting precipitate was vacuum-dried at 45° C. for 48 hours to obtain the polymer produc...

Embodiment 2

[0044] Embodiment 2, preparation TPGS-b-(PLA-ran-PGA) copolymer

[0045] Take 95% L-lactide monomer, 2% glycolide monomer and 3% polyethylene glycol 1000 vitamin E succinate (TPGS) (n=32, molecular weight 1513) as raw materials according to the mass percentage , put into the polymerization tube, add tetramethyldibutylguanidine acetate accounting for 0.5% of the total mass of the raw material, vacuumize, fill with nitrogen, repeat three times (to ensure the anaerobic condition of the equipment), the polymerization tube is sealed, at 145 ℃ heating, and reacted for 16 hours to obtain TPGS-b-(PLA-ran-PGA) copolymers (I) and (II) with a number average molecular weight of 46,000 (calculation method is the same as in Example 1).

[0046] The TPGS-b-(PLA-ran-PGA) copolymer prepared above, corresponding to (I) and (II), n is about 32, and the lactide segment (A+B+...) value is about 607, glycolide A copolymer with a segment (a+b+...) value of about 16.

Embodiment 3

[0047] Embodiment 3, preparation TPGS-b-(PLA-ran-PGA) copolymer

[0048] Take 58% racemic lactide monomer, 2% glycolide monomer and 40% polyethylene glycol 1000 vitamin E succinate (n=32, molecular weight 1513) as raw materials by mass percentage Put into the polymerization tube, add zinc powder accounting for 1% of the total mass of the raw materials, vacuumize, fill with nitrogen (to ensure the anaerobic condition of the equipment), seal the polymerization tube, heat at 145 ° C, and react for 12 hours to obtain the number average TPGS-b-(PLA-ran-PGA) copolymers (I) and (II) with a molecular weight of 4300.

[0049] TPGS-b-(PLA-ran-PGA) copolymer crude product (I) and (II) were dissolved in methylene chloride, methanol was added to make TPGS-b-(PLA-ran-PGA) copolymer precipitate, filtered, and The precipitate was vacuum-dried at 50° C. to obtain refined TPGS-b-(PLA-ran-PGA) copolymers (I) and (II) with a molecular weight of 4300.

[0050] The TPGS-b-(PLA-ran-PGA) copolymer ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses D-alpha-tocopherol polyethylene glycol 1000 succinate (TPGS)-b-(polylactide (PLA)-ran-polyglycolide (PGA)) copolymer and a preparation method and application thereof. Structural formulas of the copolymer are shown as a formula I and/or a formula II, wherein n is 20 to 140, A+B+... is 2 to 690, and a+b+... is 2 to 840. The preparation method comprises the following steps of: putting 2 to 95 mass percent of lactide monomers, 2 to 95 mass percent of glycolide monomers and 3 to 40 mass percent of D-alpha-tocopherol polyethylene glycol 1000 succinate serving as raw materials into a reactor; adding a catalyst which accounts for 0.1 to 1 percent based on the total mass of the raw materials; and reacting in the absence of oxygen at the temperature of between 140 and 160 DEG C for 12 to 20 hours to obtain the TPGS-b-(PLA-ran-PGA) copolymer. The TPGS-b-(PLA-ran-PGA) copolymer prepared by the invention has high biocompatibility and biodegradability, and is applied to the fields of medicinal preparations and tissue engineering, particularly the field of medicinal preparations for resisting and treating tumor.

Description

technical field [0001] The invention relates to a TPGS-b-(PLA-ran-PGA) copolymer and its preparation method and application. Background technique [0002] Pharmaceutical excipients are the basic materials and important components of pharmaceutical preparations, the material basis to ensure the production and development of pharmaceutical preparations, and play a key role in the formulation and production of pharmaceutical preparations. Without the research, development and application of new pharmaceutical excipients, it is impossible to vigorously develop new drug delivery system preparations. [0003] Polylactic acid (PLA, Polylactide), also known as polylactide, is a pharmaceutical excipient approved by the US FDA. It has good biocompatibility and biodegradability, non-toxic, non-irritating, high strength, and easy to process. After being enzymatically hydrolyzed in the organism, it will finally be decomposed into water and carbon dioxide, which can be completely absorbe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C08G63/664C08G63/90A61K47/34A61K9/14A61K9/16A61L17/12A61L27/18A61L31/06
Inventor 黄来强梅林
Owner SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap